Corporate Information And Statement Of Ifrs Compliance [Abstract]

Xspray Pharma - Filing #702828

Concept As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
Corporate information and statement of IFRS compliance [abstract]
Name of reporting entity or other means of identification
Xspray
Domicile of entity
Solna
Legal form of entity
aktiebolag
Country of incorporation
Sverige
Address of entity's registered office
Råsundavägen 12
Principal place of business
Sverige
Description of nature of entity's operations and principal activities
Xspray Pharma AB (publ) är ett läkemedelsbolag med ett antal produktkandidater under klinisk utveckling.
Name of parent entity
Xspray Pharma
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [text block]
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [abstract]
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [line items]
Current inventories
6 199 SEK
- SEK
Current trade payables
16 865 SEK
8 438 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.